Literature DB >> 18835033

Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.

Rui-Hong Wang1, Kundan Sengupta, Cuiling Li, Hyun-Seok Kim, Liu Cao, Cuiying Xiao, Sangsoo Kim, Xiaoling Xu, Yin Zheng, Beverly Chilton, Rong Jia, Zhi-Ming Zheng, Ettore Appella, Xin Wei Wang, Thomas Ried, Chu-Xia Deng.   

Abstract

In lower eukaryotes, Sir2 serves as a histone deacetylase and is implicated in chromatin silencing, longevity, and genome stability. Here we mutated the Sirt1 gene, a homolog of yeast Sir2, in mice to study its function. We show that a majority of SIRT1 null embryos die between E9.5 and E14.5, displaying altered histone modification, impaired DNA damage response, and reduced ability to repair DNA damage. We demonstrate that Sirt1(+/-);p53(+/-) mice develop tumors in multiple tissues, whereas activation of SIRT1 by resveratrol treatment reduces tumorigenesis. Finally, we show that many human cancers exhibit reduced levels of SIRT1 compared to normal controls. Thus, SIRT1 may act as a tumor suppressor through its role in DNA damage response and genome integrity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835033      PMCID: PMC2643030          DOI: 10.1016/j.ccr.2008.09.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  53 in total

1.  Resveratrol suppresses prostate cancer progression in transgenic mice.

Authors:  Curt E Harper; Brijesh B Patel; Jun Wang; Alireza Arabshahi; Isam A Eltoum; Coral A Lamartiniere
Journal:  Carcinogenesis       Date:  2007-08-03       Impact factor: 4.944

2.  MEC1-dependent redistribution of the Sir3 silencing protein from telomeres to DNA double-strand breaks.

Authors:  K D Mills; D A Sinclair; L Guarente
Journal:  Cell       Date:  1999-05-28       Impact factor: 41.582

3.  A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.

Authors:  Rui-Hong Wang; Hongtao Yu; Chu-Xia Deng
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

Review 4.  Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

Authors:  Bharat B Aggarwal; Anjana Bhardwaj; Rishi S Aggarwal; Navindra P Seeram; Shishir Shishodia; Yasunari Takada
Journal:  Anticancer Res       Date:  2004 Sep-Oct       Impact factor: 2.480

5.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

Authors:  Joseph T Rodgers; Carlos Lerin; Wilhelm Haas; Steven P Gygi; Bruce M Spiegelman; Pere Puigserver
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

6.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

Review 7.  The Sir2 family of protein deacetylases.

Authors:  Gil Blander; Leonard Guarente
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

8.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.

Authors:  A Nagy; J Rossant; R Nagy; W Abramow-Newerly; J C Roder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

Authors:  Taro Yamashita; Marshonna Forgues; Wei Wang; Jin Woo Kim; Qinghai Ye; Huliang Jia; Anuradha Budhu; Krista A Zanetti; Yidong Chen; Lun-Xiu Qin; Zhao-You Tang; Xin Wei Wang
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

Review 10.  Sirtuins: critical regulators at the crossroads between cancer and aging.

Authors:  L R Saunders; E Verdin
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

View more
  363 in total

1.  Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer.

Authors:  Daniel Herranz; Maribel Muñoz-Martin; Marta Cañamero; Francisca Mulero; Barbara Martinez-Pastor; Oscar Fernandez-Capetillo; Manuel Serrano
Journal:  Nat Commun       Date:  2010-04-12       Impact factor: 14.919

Review 2.  Sirtuin activators and inhibitors.

Authors:  José M Villalba; Francisco J Alcaín
Journal:  Biofactors       Date:  2012-06-25       Impact factor: 6.113

3.  SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice.

Authors:  Cuiying Xiao; Hyun-Seok Kim; Tyler Lahusen; Rui-Hong Wang; Xiaoling Xu; Oksana Gavrilova; William Jou; David Gius; Chu-Xia Deng
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

4.  Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells.

Authors:  Dharminder Chauhan; Madhavi Bandi; Ajita V Singh; Arghya Ray; Noopur Raje; Paul Richardson; Kenneth C Anderson
Journal:  Br J Haematol       Date:  2011-09-26       Impact factor: 6.998

Review 5.  Epigenetic regulation of ageing: linking environmental inputs to genomic stability.

Authors:  Bérénice A Benayoun; Elizabeth A Pollina; Anne Brunet
Journal:  Nat Rev Mol Cell Biol       Date:  2015-09-16       Impact factor: 94.444

6.  Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis.

Authors:  G Chen; B Zhang; H Xu; Y Sun; Y Shi; Y Luo; H Jia; F Wang
Journal:  Oncogene       Date:  2017-09-04       Impact factor: 9.867

Review 7.  The multifaceted functions of sirtuins in cancer.

Authors:  Angeliki Chalkiadaki; Leonard Guarente
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

8.  miRNA regulation of Sirtuin-1 expression in human astrocytoma.

Authors:  Sara Giovanna Romeo; Alfredo Conti; Francesca Polito; Chiara Tomasello; Valeria Barresi; Domenico La La Torre; Maria Cucinotta; Flavio Filippo Angileri; Marcello Bartolotta; Rosa Maria Di Giorgio; M'Hammed Aguennouz
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

9.  Sirtuin 2-mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I interferon responses.

Authors:  Ewa M Kosciuczuk; Swarna Mehrotra; Diana Saleiro; Barbara Kroczynska; Beata Majchrzak-Kita; Pawel Lisowski; Caroline Driehaus; Anna Rogalska; Acara Turner; Thomas Lienhoop; David Gius; Eleanor N Fish; Athanassios Vassilopoulos; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2018-11-28       Impact factor: 5.157

10.  Geroncogenesis: metabolic changes during aging as a driver of tumorigenesis.

Authors:  Lindsay E Wu; Ana P Gomes; David A Sinclair
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.